Subscribe To Our Free Newsletter |
Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers. According to IQVIATM (IMS Health), Ofloxacin Ophthalmic Solution USP 0.3% had US sales of approximately $52 million for the 12-
month period ending December 2023.